Formaldehyde Sulfinic Acid

Formaldehyde Sulfinic Acid

SCHEMBL4868164

O=S([O-])CO.O=S([O-])CO.[Ca+2]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Formaldehyde Sulfinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
OR51E2 Q9H255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107108837-B Thermoplastic polyurethane films for delivering active agents to skin surfaces 路博润先进材料公司 2021-04-13 CN claimed
CN-119817200-A N-type material for thermoelectric conversion, method for producing same, thermoelectric conversion element, and dopant 电化株式会社 2025-04-11 CN disclosed
US-11406578-B2 Process for stripping keratin fibres using a composition comprising a sulfinic acid derivative and an acidic aqueous composition L'OREAL (FR) 2022-08-09 US disclosed
CN-110050002-B Synergistic active composition L布吕格曼有限两合公司 2021-06-25 CN disclosed
EP-3494956-A2 PROCÉDÉ POUR LE DÉCAPAGE DE FIBRES KÉRATINIQUES UTILISANT UNE COMPOSITION COMPRENANT UN DÉRIVE DACIDE SULFINIQUE ET UNE COMPOSITION AQUEUSE ACIDE L'Oréal (FR) 2019-06-12 EP disclosed
EP-2642976-B1 PROCESS FOR STRIPPING KERATIN FIBRES USING A COMPOSITION COMPRISING A SULFINIC ACID DERIVATIVE AND AN ACIDIC AQUEOUS COMPOSITION OREAL (FR) 2019-02-13 EP disclosed
US-20130266529-A1 PROCESS FOR STRIPPING KERATIN FIBRES USING A COMPOSITION COMPRISING A SULFINIC ACID DERIVATIVE AND AN ACIDIC AQUEOUS COMPOSITION L'OREAL (FR) 2013-10-10 US disclosed
EP-2642976-A2 PROCESS FOR STRIPPING KERATIN FIBRES USING A COMPOSITION COMPRISING A SULFINIC ACID DERIVATIVE AND AN ACIDIC AQUEOUS COMPOSITION L'Oréal (FR) 2013-10-02 EP disclosed
WO-2012069599-A2 PROCESS FOR STRIPPING KERATIN FIBRES USING A COMPOSITION COMPRISING A SULFINIC ACID DERIVATIVE AND AN ACIDIC AQUEOUS COMPOSITION L'OREAL (FR) 2012-05-31 WO disclosed
US-7371356-B2 Method for the production of precipitated calcium carbonate with a high degree of brightness BASF AKTIENGESELLSCHAFT (DE) 2008-05-13 US disclosed
US-20050251928-A1 Method for stripping artificial color from keratin fibers L'OREAL (FR) 2005-11-17 US disclosed
US-20050158226-A1 Method for the production of precipitated calcium carbonate with a high degree of brightness BASF AKTIENGESELLSCHAFT (DE) 2005-07-21 US disclosed
US-20050132505-A9 Bleaching composition for dyed keratinous fibers LEGRAND FREDERIC (FR) 2005-06-23 US disclosed
US-20050050648-A1 Cosmetic composition containing sulphunic acid derivatives L'OREAL S.A. (FR) 2005-03-10 US disclosed
US-20050008589-A1 Cosmetic composition containing sulphinic acid derivatives L'OREAL S.A. (FR) 2005-01-13 US disclosed
US-20040034944-A1 Bleaching composition for dyed keratinous fibers L'OREAL S.A. (FR) 2004-02-26 US disclosed
US-6590111-B2 Reduction of alkyne compounds to cyclohexene derivatives using as reducing agent salt of hyposulfurous acid and/or hydroxymethanesulfinic acid BASF AKTIENGESELLSCHAFT (DE) 2003-07-08 US disclosed
US-20030060639-A1 Selective reduction of alkyne compounds GRIMMER JOHANNES (DE) 2003-03-27 US disclosed
EP-1285912-A2 Process for the selective reduction of alkynic compounds BASF AKTIENGESELLSCHAFT (DE) 2003-02-26 EP disclosed
EP-0150405-A2 Process for printing synthetic fibers BASF Aktiengesellschaft (DE) 1985-08-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11406578-B2 Process for stripping keratin fibres using a composition comprising a sulfinic acid derivative and an acidic aqueous composition KRT18, DSG1, PRKX OR51E2 2068/4885
US-20030060639-A1 Selective reduction of alkyne compounds CBR1, GRHPR, AKR1C3 OR51E2 2244/4885
US-20050132505-A9 Bleaching composition for dyed keratinous fibers KRT18, PRKDC, HKDC1 OR51E2 2664/4885
US-20040034944-A1 Bleaching composition for dyed keratinous fibers KRT18, PRKDC, HKDC1 OR51E2 2664/4885
US-20050008589-A1 Cosmetic composition containing sulphinic acid derivatives KRT18, CUTA, DSG1 OR51E2 3046/4885
US-20130266529-A1 PROCESS FOR STRIPPING KERATIN FIBRES USING A COMPOSITION COMPRISING A SULFINIC ACID DERIVATIVE AND AN ACIDIC AQUEOUS COMPOSITION KRT18, DSG1, PRKX OR51E2 2068/4885
US-20050251928-A1 Method for stripping artificial color from keratin fibers KRT18, DSG1, JUP OR51E2 3847/4885
US-20050050648-A1 Cosmetic composition containing sulphunic acid derivatives KRT18, H1-5, DSG1 OR51E2 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.